The authors reply

New England Journal of Medicine

Volumn 369, Issue 13, 2013, Pages 1278-1279

  Byrd, John C ^a   O'Brien, Susan ^b   James, Danelle F ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c PHARMACYCLICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; EPHRIN RECEPTOR A2; IBRUTINIB; VON WILLEBRAND FACTOR; ANTINEOPLASTIC AGENT; PROTEIN TYROSINE KINASE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

B CELL LEUKEMIA; B CELL LYMPHOMA; BLEEDING; CATARACT; CENTRAL NERVOUS SYSTEM HEMORRHAGE; CHRONIC LYMPHATIC LEUKEMIA; CORNEA DYSTROPHY; CORNEA OPACITY; HUMAN; LARGE CELL LYMPHOMA; LETTER; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; DRUG ANTAGONISM; FEMALE; MALE; NOTE;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; PROTEIN-TYROSINE KINASES; PYRAZOLES; PYRIMIDINES;

EID: 84884523966     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1309710     Document Type: Letter

References (3)

1. Klein BE, Klein R, Lee KE. Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. Ophthalmology 2002;109:2052-7. (Pubitemid 35222560)
2. Farooqui M, Lozier J, Valdez J, et al. Ibrutinib (PCI 32765) rapidly improves platelet counts in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients and has minimal effects on platelet aggregation. Presented at the American Society of Hematology Annual Meeting, Atlanta, December 8-11, 2012. abstract.
3. Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006;85:193-202. (Pubitemid 44107177)